Protein function
Encodes a MADS-box transcription factor.
Phenotype
Overexpressor: SVP overexpressor is late flowering under both SD and LD conditions.
[Posü¾Ž–”¼ et al., 2013][Li et al., 2015][Fujiwara et al., 2008][Yoshida et al., 2009][Cho et al., 2012][Balanzü¾Œ†”¼ et al., 2014][Hartmann et al., 2000] Single mutant: svp single mutant is early flowering under both SD and LD conditions.
[Posü¾Ž–”¼ et al., 2013][Andrü¾Ž–”¼s et al., 2014][Jang et al., 2009][Li et al., 2008][Li et al., 2015][Fujiwara et al., 2008][Lee et al., 2013][Cho et al., 2012][Balanzü¾Œ†”¼ et al., 2014][Hartmann et al., 2000] Remarks: FLC and SVP have a subset of common targets: the FLC-SVP duplex binds to multiple flowering time genes, including gibberelin-related factors. However, FLC and SVP also their own specific targets.
[Mateos et al., 2015] Remarks: SVP is involved in both flower development and control of flowering time.
[Gregis et al., 2006][Gregis et al., 2009][Gregis et al., 2008][Liu et al., 2009][Grandi et al., 2012] Function:Transcription repressor that inhibit floral transition in the autonomous flowering pathway, independent of photoperiod and temperature. Acts in a dosage-dependent manner. Together with AGL24 and AP1, controls the identity of the floral meristem and regulates expression of class B, C and E genes.
[Data from UniProt]
Regulators, targets and interactors
Downstream actors
causality FT --
[Li et al., 2008][Pos et al., 2013][Gu et al., 2013][Deng et al., 2011][Lee et al., 2007][Searle et al., 2006][Helliwell et al., 2006][Jang et al., 2009][Tao et al., 2012][Lee et al., 2013][Gregis et al., 2013][Mateos et al., 2015] --
[View TAIR record]MIR172B --
[Cho et al., 2012][Lee et al., 2010][Tao et al., 2012] --
[View TAIR record]EFM --
[Yan et al., 2014] --
[View TAIR record]LFY --
[Liu et al., 2009][Gregis et al., 2009][Grandi et al., 2012][Tao et al., 2012][Pastore et al., 2011] --
[View TAIR record]MIR172A --
[Cho et al., 2012][Lee et al., 2010][Tao et al., 2012] --
[View TAIR record]SEP3 --
[Liu et al., 2009][Liu et al., 2013][Pos et al., 2013] --
[View TAIR record]TEM2, RAV2 --
[Pos et al., 2013][Marn-Gonzlez et al., 2015] --
[View TAIR record]AP1 --
[Grandi et al., 2012] --
[View TAIR record]SOC1, AGL20 --
[Li et al., 2008][Pos et al., 2013][Gu et al., 2013][Deng et al., 2011][Searle et al., 2006][Helliwell et al., 2006][Tao et al., 2012][Lee et al., 2013][Gregis et al., 2013][Mateos et al., 2015][Hepworth et al., 2002] --
[View TAIR record]MIR172C --
[Cho et al., 2012][Lee et al., 2010][Tao et al., 2012] --
[View TAIR record]MAF2, AGL31 --
[Airoldi et al., 2015] --
[View TAIR record]SVP --
[Gregis et al., 2013] --
[View TAIR record] Upstream actors
causality FCA --
[Lee et al., 2007] --
[View TAIR record]AP1 --
[Yu et al., 2004][Wuest et al., 2012][Gregis et al., 2008][Kaufmann et al., 2010][Liu et al., 2007] --
[View TAIR record]AP3 --
[Wuest et al., 2012] --
[View TAIR record]SVP --
[Gregis et al., 2013] --
[View TAIR record]PI --
[Wuest et al., 2012] --
[View TAIR record]FVE, MSI4 --
[Lee et al., 2007] --
[View TAIR record]SEP3 --
[Wuest et al., 2012][Gregis et al., 2008][Kaufmann et al., 2010][Liu et al., 2007] --
[View TAIR record] Protein-protein interactions
AGL16 --
[Hu et al., 2014] --
[View TAIR record]TFL2, LHP1 --
[Liu et al., 2009] --
[View TAIR record]MAF2, AGL31 --
[Airoldi et al., 2015] --
[View TAIR record] GI --
[Sawa et al., 2011] --
[View TAIR record]FLM, MAF1, AGL27 --
[Pos et al., 2013][Lee et al., 2013] --
[View TAIR record]ELF3 --
[Yoshida et al., 2009] --
[View TAIR record]FLC, AGL25, FLF --
[Li et al., 2008][Fujiwara et al., 2008][Hu et al., 2014] --
[View TAIR record]